Published in Drug Week, February 24th, 2006
The successful outcome of this trial would serve as one of two pivotal trials required for a new drug application (NDA), which the company hopes to file with the United States Food & Drug Administration as early as year end 2008.
Carol R. Reed, MD, the company's chief medical officer, said, "Following our recent meeting with the staff of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.